PC
Padmaja Chigurupati
About Padmaja Chigurupati
Data last updated:
Padmaja Chigurupati is a Director at Hyderabad Institute Of Oncology Private Limited (since 2010), Director at Haragovind Enterprises Private Limited (since 2021) and Director at Guntur Institute Of Oncology Private Limited (since 2023), and holds 10 more current directorships. The companies operate in Healthcare, Financial Services and Pharma. The 10 current companies with reported revenue have a combined latest revenue of ₹1,086 Cr; the largest is Hyderabad Institute Of Oncology Private Limited at ₹486 Cr (FY 2025). Earlier, Padmaja Chigurupati was a Director at Hyderabad Institute Of Neuro Sciences Private Limited (2016–2017) and Additional Director at Harikrishna Institute Of Oncology Private Limited (from 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hyderabad Institute Of Oncology Private Limited U85110TG2010PTC066521 | Director | 27 Mar 2010 | 2010 | ₹486 Cr (FY 2025) | Active |
 Haragovind Enterprises Private Limited U85195AP2015PTC096073 | Director | 27 Dec 2021 | 2015 | ₹285 Cr (FY 2023) | Active |
| Guntur Institute Of Oncology Private Limited U85195AP2014PTC095682 | Director | 01 Feb 2023 | 2014 | ₹95.46 Cr (FY 2025) | Active |
 Cytecare Hospitals Private Limited U85110GJ2014PTC079078 | Director | 03 Nov 2025 | 2014 | ₹93.10 Cr (FY 2024) | Active |
| Kurnool Institute Of Oncology Private Limited U93030AP2014PTC095320 | Director | 20 May 2016 | 2014 | ₹61.84 Cr (FY 2025) | Active |
| Sathavahana Institute Of Oncology Private Limited U85300TG2019PTC130747 | Director | 09 Jan 2022 | 2019 | ₹17.85 Cr (FY 2025) | Active |
| Oncochain Healthcare Services Private Limited U85100DL2019PTC347937 | Director | 31 Jan 2022 | 2019 | ₹17.62 Cr (FY 2025) | Active |
| Hare Krishna Superspeciality Hospitals Private Limited U85110TG2021PTC156835 | Director | 06 Apr 2024 | 2021 | ₹15.30 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Hyderabad Institute Of Neuro Sciences Private Limited U85191TG2015PTC101107 | Director | 04 Feb 2016 | 2015 | ₹133 Cr (FY 2025) | Active |
| Harikrishna Institute Of Oncology Private Limited U85190TG2020PTC144475 | Additional Director | 05 Oct 2022 | 2020 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Padmaja Chigurupati
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Padmaja Chigurupati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Padmaja Chigurupati
Padmaja Chigurupati currently holds 13 directorships: Hyderabad Institute Of Oncology Private Limited (Director, since 27 Mar 2010, revenue ₹486 Cr (FY 2025)); Haragovind Enterprises Private Limited (Director, since 27 Dec 2021, revenue ₹285 Cr (FY 2023)); Guntur Institute Of Oncology Private Limited (Director, since 01 Feb 2023, revenue ₹95.46 Cr (FY 2025)); Cytecare Hospitals Private Limited (Director, since 03 Nov 2025, revenue ₹93.10 Cr (FY 2024)); Kurnool Institute Of Oncology Private Limited (Director, since 20 May 2016, revenue ₹61.84 Cr (FY 2025)); and 8 more.
Padmaja Chigurupati was first appointed on 27 Mar 2010 as Director at Hyderabad Institute Of Oncology Private Limited. The most recent appointment on record is 03 Nov 2025 at Cytecare Hospitals Private Limited.
The 10 current companies of Padmaja Chigurupati that report revenue have a combined latest revenue of ₹1,086 Cr: Hyderabad Institute Of Oncology Private Limited ₹486 Cr (FY 2025); Haragovind Enterprises Private Limited ₹285 Cr (FY 2023); Guntur Institute Of Oncology Private Limited ₹95.46 Cr (FY 2025); Cytecare Hospitals Private Limited ₹93.10 Cr (FY 2024); Kurnool Institute Of Oncology Private Limited ₹61.84 Cr (FY 2025); and 5 more.
Padmaja Chigurupati held 2 earlier board appointments: Hyderabad Institute Of Neuro Sciences Private Limited (Director, 04 Feb 2016 to 26 Sep 2017); Harikrishna Institute Of Oncology Private Limited (Additional Director, from 05 Oct 2022).
The current boards of Padmaja Chigurupati's companies include Arjun Saigal (Hyderabad Institute Of Oncology Private Limited), Jasthi Krishna Kishore (Hyderabad Institute Of Oncology Private Limited), Mohan Vamsy Chigurupati (Hyderabad Institute Of Oncology Private Limited), Nagavardhanamma Parvathaneni (Hyderabad Institute Of Oncology Private Limited), Hara Govind Chigurupati (Haragovind Enterprises Private Limited), Gopala Naga Maddula Kishore (Guntur Institute Of Oncology Private Limited), among others.